Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / UNIT 10/15/2029
Symbol
DMAAU on Nasdaq
Price per share
$10.45
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
660,204
Total reported value
$6,731,720
% of total 13F portfolios
0%
Share change
-327,488
Value change
-$3,517,894
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 8 institutional investors reported holding 660,204 shares of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU).

Institutional Holders of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$208,000 $10.45 0
2025 Q3 660,204 $6,731,720 -$3,517,894 $10.40 8
2025 Q2 986,129 $10,176,850 -$23,363,643 $10.32 9
2025 Q1 3,289,223 $33,388,110 +$33,388,110 $10.17 15